Influence of monoamine oxidase inhibitors on the cardiovascular action of some analgesics.
D000700:Analgesics / Q000494:pharmacology*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D001831:Body Temperature / Q000187:drug effects; D002319:Cardiovascular System / Q000187:drug effects*; D002404:Catheterization; D003864:Depression, Chemical; D004357:Drug Synergism; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006584:Hexamethonium Compounds / Q000494:pharmacology; D008297:Male; D008614:Meperidine / Q000494:pharmacology; D008722:Methods; D008781:Methyltyrosines / Q000494:pharmacology; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D009020:Morphine / Q000494:pharmacology; D010423:Pentazocine / Q000494:pharmacology; D010624:Phenelzine / Q000494:pharmacology; D010627:Phenethylamines / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D013268:Stimulation, Chemical; D013997:Time Factors
D000700:Analgesics; D006584:Hexamethonium Compounds; D008781:Methyltyrosines; D008996:Monoamine Oxidase Inhibitors; D010627:Phenethylamines; D009020:Morphine; D012110:Reserpine; D008614:Meperidine; D010624:Phenelzine; D010423:Pentazocine; D010646:Phentolamine